nifedipine has been researched along with Leukemia, Myeloid in 2 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazill, GW | 1 |
| Dexter, TM | 1 |
| Waschke, K | 1 |
| von Baehr, R | 1 |
| Wolf, G | 1 |
2 other studies available for nifedipine and Leukemia, Myeloid
| Article | Year |
|---|---|
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; End | 1990 |
The action of calcium antagonists in the human natural killer cell-mediated cytotoxicity.
Topics: Cell Line; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Leukemia, Myeloid; Nifedipine; | 1987 |